Analysed CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) News Sources
Assessing Celldex Therapeutics (CLDX) Valuation After Recent Share Price Pullback And Mixed Signals
12-05-2026
yahoo.com
[Latest] Global Cholera Vaccine Market Size/Share Worth USD 649 Million by 2035 at a 7.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
19-05-2026
yahoo.com
Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
10-06-2026
yahoo.com
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
14-06-2026
yahoo.com
Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting
14-06-2026
yahoo.com
Celldex Therapeutics (CLDX) Stock Valuation Check After Recent Share Price Momentum
15-06-2026
yahoo.com
Chronic Spontaneous Urticaria Market Heats Up as Pharma Companies Race to Address Unmet Needs | DelveInsight
24-06-2026
yahoo.com
What is the current price of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?
The current price of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is $39.11.
CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) since the previous trading day is $0.13.
CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) since the previous trading day is 0.3335%.
What is the most recent average sentiment score for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?
The most recent average sentiment score for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?
The most recent sentiment for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is .
SEC-8K** Filing Available For CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.